Cargando…

Clinical comments related to medullary thyroid cancer diagnosis and management

BACKGROUND: The American Thyroid Association (ATA) and more recently the European Thyroid Association (ETA) Guidelines on diagnosis and treatment of medullary thyroid carcinoma (MTC) have provided an excellent tool which was formerly lacking in the field of management of MTC. However, some relevant...

Descripción completa

Detalles Bibliográficos
Autor principal:	Duntas, Leonidas H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599727/ https://www.ncbi.nlm.nih.gov/pubmed/23514614 http://dx.doi.org/10.1186/1756-6614-6-S1-S6

Ejemplares similares

Introduction to European comments on “Medullary Thyroid Cancer: management guidelines of the American Thyroid Association”
por: Jarzab, Barbara, et al.
Publicado: (2013)

Diagnosis of medullary thyroid cancer
por: Marchisotta, Stefania, et al.
Publicado: (2009)

An Introduction to Managing Medullary Thyroid Cancer
por: de Groot, Jan Willem, et al.
Publicado: (2006)

COVID-19 and Thyroid Diseases: A Bidirectional Impact
por: Duntas, Leonidas H, et al.
Publicado: (2021)

Advanced medullary thyroid cancer: pathophysiology and management
por: Ferreira, Carla Vaz, et al.
Publicado: (2013)

Role of vandetanib in the management of medullary thyroid cancer
por: Brassard, Maryse, et al.
Publicado: (2012)

On the Centennial of Vitamin D—Vitamin D, Inflammation, and Autoimmune Thyroiditis: A Web of Links and Implications
por: Duntas, Leonidas H., et al.
Publicado: (2022)

Update on the Diagnosis and Management of Medullary Thyroid Cancer: What Has Changed in Recent Years?
por: Kaliszewski, Krzysztof, et al.
Publicado: (2022)

Pregnancy, thyroid, and the potential use of selenium
por: Hubalewska-Dydejczyk, Alicja, et al.
Publicado: (2019)

Medullary thyroid cancer: molecular factors, management and treatment
por: Pavlidis, Efstathios, et al.
Publicado: (2020)

New Diagnostic and Therapeutic Tools for Thyroid Cancer
por: Fröhlich, Eleonore, et al.
Publicado: (2013)

A Renewed Focus on the Association Between Thyroid Hormones and Lipid Metabolism
por: Duntas, Leonidas H., et al.
Publicado: (2018)

Management of medullary carcinoma of the thyroid: a review
por: Jayasinghe, Ravindri, et al.
Publicado: (2022)

Treatment of advanced medullary thyroid cancer
por: Smit, Johannes
Publicado: (2013)

Recent Updates on the Management of Medullary Thyroid Carcinoma
por: Kim, Bo Hyun, et al.
Publicado: (2016)

Current Guidelines for Management of Medullary Thyroid Carcinoma
por: Kim, Mijin, et al.
Publicado: (2021)

Medullary Thyroid Cancer: Updates and Challenges
por: Gild, Matti L, et al.
Publicado: (2023)

Editorial: Treatment of subclinical thyroid dysfunction in patients with comorbidities
por: Razvi, Salman, et al.
Publicado: (2023)

Selenium and at-risk pregnancy: challenges and controversies
por: Duntas, Leonidas H.
Publicado: (2020)

Genetic and Epigenetic of Medullary Thyroid Cancer
por: Khatami, Fatemeh, et al.
Publicado: (2018)

The Evolving Role of Selenium in the Treatment of Graves' Disease and Ophthalmopathy
por: Duntas, Leonidas H.
Publicado: (2012)

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
por: Degrauwe, Nils, et al.
Publicado: (2012)

How I treat medullary thyroid cancer
por: Kiesewetter, B., et al.
Publicado: (2021)

Clinical utility of vandetanib in the treatment of patients with advanced medullary thyroid cancer
por: Deshpande, Hari, et al.
Publicado: (2011)

Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies
por: Grande, Enrique, et al.
Publicado: (2013)

Management of lymph nodes in medullary thyroid carcinoma: A review
por: Shaghaghi, Ali, et al.
Publicado: (2022)

Targeted Treatment of Differentiated and Medullary Thyroid Cancer
por: Bales, Shannon R., et al.
Publicado: (2011)

DIAGNOSIS OF ENDOCRINE DISEASE: Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper
por: Giovanella, Luca, et al.
Publicado: (2014)

Levothyroxine Dose Adjustment to Optimise Therapy Throughout a Patient’s Lifetime
por: Duntas, Leonidas H., et al.
Publicado: (2019)

Efficacy and Tolerability of Pharmacotherapy Options for the Treatment of Medullary Thyroid Cancer
por: Deshpande, H. A., et al.
Publicado: (2012)

Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer
por: Deshpande, Hari, et al.
Publicado: (2011)

Genetic susceptibility to hereditary non-medullary thyroid cancer
por: Kamani, Tina, et al.
Publicado: (2022)

From Circulating Tumor Cells to Mirna: New Challenges in the Diagnosis and Prognosis of Medullary Thyroid Cancer
por: Ricci, Claudia, et al.
Publicado: (2023)

Hypercalcitoninemia is not Pathognomonic of Medullary Thyroid Carcinoma
por: Toledo, Sergio PA, et al.
Publicado: (2009)

Significance of RAS Mutations in Thyroid Benign Nodules and Non-Medullary Thyroid Cancer
por: Marotta, Vincenzo, et al.
Publicado: (2021)

New Opportunities for Preoperative Diagnosis of Medullary Thyroid Carcinoma
por: Lukyanov, Sergei A., et al.
Publicado: (2023)

Diarrhea as an Initial Presentation in Patients with Medullary Thyroid Cancer: Delaying the Diagnosis
por: Shakir, Mohamed K.M., et al.
Publicado: (2020)

Profile of cabozantinib and its potential in the treatment of advanced medullary thyroid cancer
por: Hart, Christopher D, et al.
Publicado: (2013)

Medullary Thyroid Carcinoma: An Update on Imaging
por: Kushchayev, Sergiy V., et al.
Publicado: (2019)

Cabozantinib for progressive metastatic medullary thyroid cancer: a review
por: Colombo, Joshua R, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_20pmegaugbqgd1ifs1g853f355